CONSTRUCTION of Moderna's manufacturing site at Monash University's Clayton campus, has commenced.
The start of work on the site came less than four months after the vaccine manufacturer announced it would build a plant at Monash as part of its 10-year strategic partnership with the Federal and Victorian governments.
The facility is expected to open in 2024, and produce up to 100 million doses of COVID-19, influenza and respiratory syncytial virus (RSV) vaccines a year.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Dec 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Dec 22
